-
,for, Item ID-
- #1224369
- Cue Health Inc #C1020
Respiratory Test Kit Cue® COVID-19 10 Tests
TEST KIT, COVID-19 RAPID PRO (10/BX) D/S
Features
- The Cue™ COVID-19 Test is for use under an Emergency use Authorization (EUA) Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
- Cue COVID-19 Test is an isothermal nucleic acid amplification assay intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in direct anterior nasal swabs or in previously collected anterior nasal swab specimens in viral transport media from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19
- The test is run using the Cue Health Monitoring System (Cue Cartridge Reader), the Cue COVID-19 Test Cartridge, the Cue Sample Wand, and the Cue Health App on the compatible mobile smart devices named on the Cue Health website at www.cuehealth.com
- More …
Product Details Email
Product Specifications
McKesson # | 1224369 |
---|---|
Manufacturer # | C1020 |
Brand | Cue® |
Manufacturer | Cue Health Inc |
Country of Origin | Unknown |
Application | Respiratory Test Kit |
Contents 1 | (10) Cue COVID-19 Test Cartridge Pack: Foil Pouch with Plastic Tray with (1) Single-Use Test Cartridge and (1) Single-Use Wrapped Sterile Cue Sample Wand |
For Use With | For use with Cue Health Monitoring System and Cue Health Mobile Application |
HCPCS | K1034 |
Number of Tests | 10 Tests |
Product Dating | McKesson Acceptable Dating: we will ship >= 30 days |
Purchase Program Type | Standard Purchase |
Reading Type | Machine Read |
Sample Type | Nasal Swab Sample |
Specialty | Molecular |
Test Format | Cartridge Format |
Test Kit Type | Rapid |
Test Method | Isothermal Amplication |
Test Name | COVID-19 |
Test Type | Molecular Diagnostic |
Time to Results | 20 Minute Results |
UNSPSC Code | 41116205 |
Features
- The Cue™ COVID-19 Test is for use under an Emergency use Authorization (EUA) Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
- Cue COVID-19 Test is an isothermal nucleic acid amplification assay intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in direct anterior nasal swabs or in previously collected anterior nasal swab specimens in viral transport media from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19
- The test is run using the Cue Health Monitoring System (Cue Cartridge Reader), the Cue COVID-19 Test Cartridge, the Cue Sample Wand, and the Cue Health App on the compatible mobile smart devices named on the Cue Health website at www.cuehealth.com
- Cue COVID-19 Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high, moderate or waived complexity tests
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Testing facilities within the United States and its territories are required to report all results to the appropriate public health authorities
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions
- Negative results in an asymptomatic individual are presumptive and confirmation may be performed for patient management, if necessary, with a different molecular test in a laboratory
- Required materials not provided: Cue Health Monitoring System, Mobile Smart Device, Cue Health Mobile App installed on Mobile Smart Device, and Control Swabs (Ref C2110)
More Information
Professionals Also Viewed
-
,for, Item ID-
- #1076728
- Providers like you icon 7,390
- McKesson Brand #181-36025
- Rapid qualitative test that detects Influenza type A and type B antige …
- Color-coded control swab packaging for easy positive/negative identifi …
- Results in under 15 minutes
-
,for, Item ID-
- #951316
- Providers like you icon 5,936
- McKesson Brand #5003
- A rapid test for the qualitative detection of Strep A antigen in throa …
- CLIA waived and easy to use
- Contents: 25 Dipsticks (in sealed pouches), Disposable extraction test …
-
,for, Item ID-
- #951312
- Providers like you icon 4,867
- McKesson Brand #4999
- A rapid test for the qualitative detection of Strep A antigen in throa …
- CLIA waived and easy to use
- Contents: 50 Dipsticks (2 vials of 25), Disposable extraction test tub …
-
,for, Item ID-
- #1127458
- Providers like you icon 500
- McKesson Brand #181-34125
- A rapid test for the qualitative detection of Strep A antigen in throa …
- Easy-to-use flip step eliminates need for pipetting
- Fast, accurate detection of Group A Strep with walk-away convenience